SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+3.9%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$423M
AUM Growth
+$423M
(+1.4%)
Cap. Flow
-$3.04M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
61.07%
Holding
37
New
6
Increased
16
Reduced
8
Closed
6
Top Buys
| 1 |
HSP
HOSPIRA INC
HSP
|
$12M |
| 2 |
Eli Lilly
LLY
|
$8.03M |
| 3 |
Cencora
COR
|
$7.27M |
| 4 |
Boston Scientific
BSX
|
$6.47M |
| 5 |
Dr. Reddy's Laboratories
RDY
|
$6.31M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$18.4M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$12.4M |
| 3 |
AbbVie
ABBV
|
$12.1M |
| 4 |
UnitedHealth
UNH
|
$9.71M |
| 5 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
$9.38M |
Sector Composition
| 1 | Healthcare | 88.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$657B
| $57M | 13.47% | 916,147 +129,200 | +16% | +$8.03M |
|
2
Baxter International
BAX
$12.7B
| $39.2M | 9.27% | 541,800 -40,900 | -7% | -$2.96M |
|
|
3
Boston Scientific
BSX
$156B
| $32.2M | 7.61% | 2,517,600 +506,800 | +25% | +$6.47M |
|
4
Edwards Lifesciences
EW
$47.8B
| $25.8M | 6.1% | 300,300 -13,300 | -4% | -$1.14M |
|
|
THOR
5
DELISTED
THORATEC CORPORATION
THOR
| $19.5M | 4.6% | 558,300 +171,000 | +44% | +$5.96M |
|
6
Revvity
RVTY
$10.5B
| $18.5M | 4.38% | 395,460 +39,500 | +11% | +$1.85M |
|
7
Ironwood Pharmaceuticals
IRWD
$214M
| $17.8M | 4.2% | 1,158,491 +131,500 | +13% | +$2.02M |
|
8
Teva Pharmaceuticals
TEVA
$21.1B
| $17.5M | 4.15% | 334,600 -55,400 | -14% | -$2.9M |
|
9
Quest Diagnostics
DGX
$20.3B
| $16.6M | 3.93% | 283,128 +24,000 | +9% | +$1.41M |
|
10
Cardinal Health
CAH
$35.5B
| $14.2M | 3.36% | 207,000 +1,300 | +0.6% | +$89.1K |
|
|
CBST
11
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $13.4M | 3.18% | 192,490 +26,100 | +16% | +$1.82M |
|
12
Tenet Healthcare
THC
$16.3B
| $13.1M | 3.09% | 278,200 +104,200 | +60% | +$4.89M |
|
|
13
AbbVie
ABBV
$372B
| $12.9M | 3.05% | 228,500 -214,900 | -48% | -$12.1M |
|
|
ACOR
14
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $12.6M | 2.99% | 374,600 +123,900 | +49% | +$4.18M |
|
15
ResMed
RMD
$40.2B
| $12.6M | 2.99% | 249,300 +28,300 | +13% | +$1.43M |
|
|
LPNT
16
DELISTED
LifePoint Health, Inc.
LPNT
| $12.4M | 2.93% | 199,700 -3,200 | -2% | -$199K |
|
|
HSP
17
DELISTED
HOSPIRA INC
HSP
| $12M | 2.84% | +233,800 | New | +$12M |
|
|
PDCO
18
DELISTED
Patterson Companies, Inc.
PDCO
| $10.2M | 2.42% | 258,465 +38,300 | +17% | +$1.51M |
|
19
Agilent Technologies
A
$35.7B
| $9.6M | 2.27% | 167,200 -42,800 | -20% | -$2.46M |
|
20
Bio-Rad Laboratories Class A
BIO
$8.06B
| $7.94M | 1.88% | 66,300 +6,400 | +11% | +$766K |
|
|
21
Cencora
COR
$56.5B
| $7.27M | 1.72% | +100,000 | New | +$7.27M |
|
|
22
Dr. Reddy's Laboratories
RDY
$11.8B
| $6.31M | 1.49% | +146,152 | New | +$6.31M |
|
|
MDCO
23
DELISTED
Medicines Co
MDCO
| $5.35M | 1.27% | 184,250 +56,700 | +44% | +$1.65M |
|
24
Bristol-Myers Squibb
BMY
$96B
| $5.34M | 1.26% | +110,000 | New | +$5.34M |
|
|
CTRX
25
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $5.01M | 1.19% | 113,500 +53,500 | +89% | +$2.36M |
|